MedPath

Edenbridge Pharmaceuticals, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

32

FDA:26
CANADA:3

Drug Approvals

Donepezil hydrochloride

Approval Date
Aug 1, 2025
FDA

Isosorbide Mononitrate

Approval Date
Jun 6, 2025
FDA

Bisoprolol Fumarate and Hydrochlorothiazide

Approval Date
Jan 17, 2024
FDA

Venlafaxine

Approval Date
Jan 4, 2024
FDA

venlafaxine hydrochloride, extended release

Approval Date
Jan 4, 2024
FDA

Prednisolone Sodium Phosphate

Approval Date
Dec 4, 2023
FDA

Ivermectin

Approval Date
Nov 20, 2023
FDA

DARTISLA ODT

Approval Date
Oct 19, 2023
FDA

Diclofenac Sodium

Approval Date
Oct 18, 2023
FDA

Yargesa

Approval Date
Oct 11, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.